Showing results (841-850 of 5,269) with videos related to

Sort By:
Pageof 527
European Journal of Haematology|January 31, 2013
Clinical utility of a panfungal polymerase chain reaction assay for invasive fungal diseases in patients with haematologic disordersYumiko Sugawara, Kazunori Nakase, Akiko Nakamura, et al.
European Journal of Haematology|February 27, 2013
Diagnostic potential of hepcidin testing in pediatricsGiuliana Cangemi, Angela Pistorio, Maurizio Miano, et al.
European Journal of Haematology|March 1, 2013
Characterization and prognostic significance of mitochondrial DNA variations in acute myeloid leukemiaTrine Silkjaer, Jan Maxwell Nørgaard, Anni Aggerholm, et al.
European Journal of Haematology|February 1, 1990
Platelets of patients affected with essential thrombocythemia are abnormal in plasma membrane and adenine nucleotide contentG Leoncini, M Maresca, E Buzzi, et al.
European Journal of Haematology|February 1, 1990
Comparative study of immunocytochemical staining versus Giemsa stain for detecting dysmegakaryopoiesis in myelodysplastic syndromes (MDS)M Kawaguchi, Y Nehashi, S Aizawa, et al.
European Journal of Haematology|February 1, 1990
Bone marrow histopathology in primary myelofibrosis: clinical and haematologic correlations and prognostic evaluationA Pereira, F Cervantes, R Brugues, et al.
European Journal of Haematology|January 9, 2013
Weekly intravenous bortezomib is effective and well tolerated in relapsed/refractory myelomaSally Moore, Sangeeta Atwal, Sajitha Sachchithanantham, et al.
European Journal of Haematology|December 11, 2012
Disclosure of myelodysplastic syndrome diagnosis: improving patients' understanding and experienceCaroline Besson, Sandrine Rannou, Hicham Elmaaroufi, et al.
European Journal of Haematology|January 4, 2013
Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patientsShigeichi Shoji, Masaaki Inaba, Naohisa Tomosugi, et al.
European Journal of Haematology|January 4, 2013
Long-term molecular remission with lenalidomide treatment of relapsed chronic lymphocytic leukemiaFrancesco Spina, Francesca Rezzonico, Lucia Farina, et al.
Pageof 527